Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 2 | 0 | 1 | 1 | 0 |
| Gross Profit | 2 | 0 | 1 | 1 | 0 |
| Operating Expenses | 11 | 41 | 8 | 12 | 14 |
| Operating Income | -9 | -40 | -7 | -12 | -13 |
| Pre-tax Income | -9 | -40 | -7 | -12 | -13 |
| Net Income Continuous | -9 | -40 | -7 | -12 | -13 |
| Net Income | $-9 | $-40 | $-7 | $-12 | $-13 |
| EPS Basic Continuous Ops | -0.31 | -1.67 | -0.29 | -0.49 | -0.56 |
| EPS Diluted Continuous Ops | -0.31 | -1.67 | -0.29 | -0.49 | -0.56 |
| EBITDA(a) | $-9 | $-40 | $-7 | $-12 | $-13 |